Literature DB >> 33951190

Paying for performance to improve the delivery of health interventions in low- and middle-income countries.

Karin Diaconu1, Jennifer Falconer1, Adrian Verbel2, Atle Fretheim3,4, Sophie Witter1.   

Abstract

BACKGROUND: There is growing interest in paying for performance (P4P) as a means to align the incentives of healthcare providers with public health goals. Rigorous evidence on the effectiveness of these strategies in improving health care and health in low- and middle-income countries (LMICs) is lacking; this is an update of the 2012 review on this topic.
OBJECTIVES: To assess the effects of paying for performance on the provision of health care and health outcomes in low- and middle-income countries. SEARCH
METHODS: We searched CENTRAL, MEDLINE, Embase, and 10 other databases between April and June 2018. We also searched two trial registries, websites, online resources of international agencies, organizations and universities, and contacted experts in the field. Studies identified from rerunning searches in 2020 are under 'Studies awaiting classification.' SELECTION CRITERIA: We included randomized or non-randomized trials, controlled before-after studies, or interrupted time series studies conducted in LMICs (as defined by the World Bank in 2018). P4P refers to the transfer of money or material goods conditional on taking a measurable action or achieving a predetermined performance target. To be included, a study had to report at least one of the following outcomes: patient health outcomes, changes in targeted measures of provider performance (such as the delivery of healthcare services), unintended effects, or changes in resource use. DATA COLLECTION AND ANALYSIS: We extracted data as per original review protocol and narratively synthesised findings. We used standard methodological procedures expected by Cochrane. Given diversity and variability in intervention types, patient populations, analyses and outcome reporting, we deemed meta-analysis inappropriate. We noted the range of effects associated with P4P against each outcome of interest. Based on intervention descriptions provided in documents, we classified design schemes and explored variation in effect by scheme design. MAIN
RESULTS: We included 59 studies: controlled before-after studies (19), non-randomized (16) or cluster randomized trials (14);  and interrupted time-series studies (9). One study included both an interrupted time series and a controlled before-after study. Studies focused on a wide range of P4P interventions, including target payments and payment for outputs as modified by quality (or quality and equity assessments). Only one study assessed results-based aid. Many schemes were funded by national governments (23 studies) with the World Bank funding most externally funded schemes (11 studies). Targeted services varied; however, most interventions focused on reproductive, maternal and child health indicators. Participants were predominantly located in public or in a mix of public, non-governmental and faith-based facilities (54 studies). P4P was assessed predominantly at health facility level, though districts and other levels were also involved. Most studies assessed the effects of P4P against a status quo control (49 studies); however, some studies assessed effects against comparator interventions (predominantly enhanced financing intended to match P4P funds (17 studies)). Four studies reported intervention effects against both comparator and status quo. Controlled before-after studies were at higher risk of bias than other study designs. However, some randomised trials were also downgraded due to risk of bias. The interrupted time-series studies provided insufficient information on other concurrent changes in the study context. P4P compared to a status quo control For health services that are specifically targeted, P4P may slightly improve health outcomes (low certainty evidence), but few studies assessed this. P4P may also improve service quality overall (low certainty evidence); and probably increases the availability of health workers, medicines and well-functioning infrastructure and equipment (moderate certainty evidence). P4P may have mixed effects on the delivery and use of services (low certainty evidence) and may have few or no distorting unintended effects on outcomes that were not targeted (low-certainty evidence), but few studies assessed these. For secondary outcomes, P4P may make little or no difference to provider absenteeism, motivation or satisfaction (low certainty evidence); but may improve patient satisfaction and acceptability (low certainty evidence); and may positively affect facility managerial autonomy (low certainty evidence). P4P probably makes little to no difference to management quality or facility governance (low certainty evidence). Impacts on equity were mixed (low certainty evidence). For health services that are untargeted, P4P probably improves some health outcomes (moderate certainty evidence); may improve the delivery, use and quality of some health services but may make little or no difference to others (low certainty evidence); and may have few or no distorting unintended effects (low certainty evidence). The effects of P4P on the availability of medicines and other resources are uncertain (very low certainty evidence). P4P compared to other strategies For health outcomes and services that are specifically targeted, P4P may make little or no difference to health outcomes (low certainty evidence), but few studies assessed this. P4P may improve service quality (low certainty evidence); and may have mixed effects on the delivery and use of health services and on the availability of equipment and medicines (low certainty evidence). For health outcomes and services that are untargeted, P4P may make little or no difference to health outcomes and to the delivery and use of health services (low certainty evidence). The effects of P4P on service quality, resource availability and unintended effects are uncertain (very low certainty evidence). Findings of subgroup analyses Results-based aid, and schemes using payment per output adjusted for service quality, appeared to yield the greatest positive effects on outcomes. However, only one study evaluated results-based aid, so the effects may be spurious. Overall, schemes adjusting both for quality of service and rewarding equitable delivery of services appeared to perform best in relation to service utilization outcomes. AUTHORS'
CONCLUSIONS: The evidence base on the impacts of P4P schemes has grown considerably, with study quality gradually increasing. P4P schemes may have mixed effects on outcomes of interest, and there is high heterogeneity in the types of schemes implemented and evaluations conducted. P4P is not a uniform intervention, but rather a range of approaches. Its effects depend on the interaction of several variables, including the design of the intervention (e.g., who receives payments ), the amount of additional funding,  ancillary components (such as technical support) and contextual factors (including organizational context).
Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.

Entities:  

Mesh:

Year:  2021        PMID: 33951190      PMCID: PMC8099148          DOI: 10.1002/14651858.CD007899.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  135 in total

1.  Provider payment reform in China: the case of hospital reimbursement in Hainan province.

Authors:  W Yip; K Eggleston
Journal:  Health Econ       Date:  2001-06       Impact factor: 3.046

2.  The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study.

Authors:  Xingzhu Liu; Anne Mills
Journal:  Appl Health Econ Health Policy       Date:  2003       Impact factor: 2.561

3.  The effect of performance-based financing on child vaccinations in northern Nigeria.

Authors:  Ryoko Sato; Abdullahi Belel
Journal:  Vaccine       Date:  2020-01-23       Impact factor: 3.641

Review 4.  The impact of user fees on access to health services in low- and middle-income countries.

Authors:  Mylene Lagarde; Natasha Palmer
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

5.  The GRADE Working Group clarifies the construct of certainty of evidence.

Authors:  Monica Hultcrantz; David Rind; Elie A Akl; Shaun Treweek; Reem A Mustafa; Alfonso Iorio; Brian S Alper; Joerg J Meerpohl; M Hassan Murad; Mohammed T Ansari; Srinivasa Vittal Katikireddi; Pernilla Östlund; Sofia Tranæus; Robin Christensen; Gerald Gartlehner; Jan Brozek; Ariel Izcovich; Holger Schünemann; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2017-05-18       Impact factor: 6.437

6.  Impact of Performance-Based Financing in a Low-Resource Setting: A Decade of Experience in Cambodia.

Authors:  Ellen Van de Poel; Gabriela Flores; Por Ir; Owen O'Donnell
Journal:  Health Econ       Date:  2015-07-30       Impact factor: 3.046

7.  Getting to the First 90: Incentivized Peer Mobilizers Promote HIV Testing Services to Men Who Have Sex With Men Using Social Media in Mumbai, India.

Authors:  Anjana Das; Bitra George; Virupax Ranebennur; M R Parthasarathy; G S Shreenivas; Priyamvada Todankar; Amit Shrivastav; Ajay Kumar Reddy; Christopher Akolo; Michael Cassell; Sandeep Mane; Deepak Tripathi; Jiban Baishya
Journal:  Glob Health Sci Pract       Date:  2019-09-26

8.  The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi.

Authors:  Jobiba Chinkhumba; Manuela De Allegri; Stephan Brenner; Adamson Muula; Bjarne Robberstad
Journal:  BMJ Glob Health       Date:  2020-05

9.  Monetary incentives for provision of syphilis screening, Yunnan, China.

Authors:  Wanyue Zhang; Hongbin Luo; Yanling Ma; Yan Guo; Qingyan Fang; Zhifang Yang; Xiujie Zhang; Xiaobin Zhang; Manhong Jia; Xiang-Sheng Chen
Journal:  Bull World Health Organ       Date:  2017-07-01       Impact factor: 9.408

10.  Can Combining Performance-Based Financing With Equity Measures Result in Greater Equity in Utilization of Maternal Care Services? Evidence From Burkina Faso.

Authors:  Takondwa Mwase; Julia Lohmann; Saidou Hamadou; Stephan Brenner; Serge M A Somda; Hervé Hien; Michael Hillebrecht; Manuela De Allegri
Journal:  Int J Health Policy Manag       Date:  2022-03-01
View more
  10 in total

1.  Who is paid in pay-for-performance? Inequalities in the distribution of financial bonuses amongst health centres in Zimbabwe.

Authors:  Roxanne Kovacs; Garrett W Brown; Artwell Kadungure; Søren R Kristensen; Gwati Gwati; Laura Anselmi; Nicholas Midzi; Josephine Borghi
Journal:  Health Policy Plan       Date:  2022-04-13       Impact factor: 3.344

2.  Appraising pay-for-performance in healthcare in low- and middle-income countries through systematic reviews: reflections from two teams.

Authors:  Karin Diaconu; Sophie Witter; Peter Binyaruka; Josephine Borghi; Garrett W Brown; Neha Singh; Cristian A Herrera
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

Review 3.  The Lancet Global Health Commission on financing primary health care: putting people at the centre.

Authors:  Kara Hanson; Nouria Brikci; Darius Erlangga; Abebe Alebachew; Manuela De Allegri; Dina Balabanova; Mark Blecher; Cheryl Cashin; Alexo Esperato; David Hipgrave; Ina Kalisa; Christoph Kurowski; Qingyue Meng; David Morgan; Gemini Mtei; Ellen Nolte; Chima Onoka; Timothy Powell-Jackson; Martin Roland; Rajeev Sadanandan; Karin Stenberg; Jeanette Vega Morales; Hong Wang; Haja Wurie
Journal:  Lancet Glob Health       Date:  2022-04-04       Impact factor: 38.927

4.  How are health workers paid and does it matter? Conceptualising the potential implications of digitising health worker payments.

Authors:  Margaret McConnell; Mansha Mahajan; Sebastian Bauhoff; Kevin Croke; Stéphane Verguet; Marcia C Castro; Kheya Melo Furtado; Abha Mehndiratta; Misha Farzana; Sabina Faiz Rashid; Richard Cash
Journal:  BMJ Glob Health       Date:  2022-01

5.  Satisfaction of Township Hospitals Health Workers on How They Are Paid in China.

Authors:  Beibei Yuan; Yahang Yu; Hongni Zhang; Huiwen Li; Chen Kong; Wei Zhang
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

Review 6.  Performance-based incentives and community health workers' outputs, a systematic review.

Authors:  Thomas Gadsden; Sikhumbuzo A Mabunda; Anna Palagyi; Asri Maharani; Sujarwoto Sujarwoto; Michelle Baddeley; Stephen Jan
Journal:  Bull World Health Organ       Date:  2021-08-20       Impact factor: 9.408

7.  Dying to know: does performance-based financing reduce mortality?

Authors:  I Bonfrer
Journal:  Health Policy Plan       Date:  2022-03-04       Impact factor: 3.344

Review 8.  Reviewing the evidence on health financing for effective coverage: do financial incentives work?

Authors:  Damien de Walque; Eeshani Kandpal
Journal:  BMJ Glob Health       Date:  2022-09

9.  Performance bonuses and the quality of primary health care delivered by family health teams in Brazil: A difference-in-differences analysis.

Authors:  Nasser Fardousi; Everton Nunes da Silva; Roxanne Kovacs; Josephine Borghi; Jorge O M Barreto; Søren Rud Kristensen; Juliana Sampaio; Helena Eri Shimizu; Luciano B Gomes; Letícia Xander Russo; Garibaldi D Gurgel; Timothy Powell-Jackson
Journal:  PLoS Med       Date:  2022-07-07       Impact factor: 11.613

10.  Can patients improve the quality of care they receive? Experimental evidence from Senegal.

Authors:  Roxanne J Kovacs; Mylene Lagarde; John Cairns
Journal:  World Dev       Date:  2022-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.